Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
43,69 USD | +3,12% | +1,91% | -8,64% |
Omzet 2024 * | 515 mln. 483 mln. | Omzet 2025 * | 630 mln. 592 mln. | Marktkapitalisatie | 3,6 mld. 3,38 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -532 mln. -500 mln. | Nettowinst (verlies) 2025 * | -457 mln. -429 mln. | EV/omzet 2024 * | 6,34 x |
Nettoliquiditeiten 2024 * | 334 mln. 314 mln. | Nettoliquiditeiten 2025 * | 298 mln. 280 mln. | EV/omzet 2025 * | 5,23 x |
K/w-verhouding 2024 * |
-6,77
x | K/w-verhouding 2025 * |
-8,38
x | Werknemers | 1.276 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,88% |
Recentste transcriptie over Ultragenyx Pharmaceutical Inc.
1 dag | +3,12% | ||
1 week | +1,91% | ||
Lopende maand | -6,43% | ||
1 maand | -4,71% | ||
3 maanden | -2,11% | ||
6 maanden | +31,91% | ||
Lopend jaar | -8,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Emil Kakkis
FOU | Founder | 63 | 22-04-10 |
Howard Horn
DFI | Director of Finance/CFO | 47 | 16-10-23 |
Eric Crombez
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Dunsire
BRD | Director/Board Member | 61 | 06-04-17 |
Emil Kakkis
FOU | Founder | 63 | 22-04-10 |
Daniel Welch
CHM | Chairman | 66 | 08-04-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
2.21% | 1 M€ | 0,00% | - | |
0.82% | 4 M€ | +20,15% | ||
0.43% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 43,69 | +3,12% | 592 387 |
19-04-24 | 42,37 | -2,33% | 676 054 |
18-04-24 | 43,38 | -1,65% | 768 249 |
17-04-24 | 44,11 | +4,25% | 908 192 |
16-04-24 | 42,31 | -1,31% | 886 829 |
uitgestelde koers Nasdaq, 22 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,64% | 3,6 mld. | |
+2,49% | 96,73 mld. | |
+0,06% | 21,31 mld. | |
-16,61% | 21,21 mld. | |
-5,80% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-27,40% | 13,68 mld. | |
+1,44% | 13,44 mld. | |
+21,29% | 10,98 mld. | |
-21,79% | 8,56 mld. |